Anika Therapeutics

ANIKA THERAPEUTICS INC

Anika Therapeutics Inc is an orthopedic medicines company. It is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies. The company focuses on orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies. Geographically, it derives a majority of its revenue from the United States and also has its presence in Europe and Other countries.

Microsoft Corp.

News

Price Target

Markets

Analyst Ratings

Trading Ideas

ADBE

ANIK

INTC

MRCY

MSFT

PATH

Microsoft To Rally More Than 17%? Here Are 10 Top Analyst Forecasts For Thursday

What The Future Might Hold

Earnings

Equities

Market Summary

Futures

Economics

Pre-Market Outlook

ADTX

GIII

NVDA

TSLA

ULTA

U.S. stock futures fell again on Thursday after a brief respite on Wednesday, following a softer-than-expected inflation print.

US Stocks Likely To Open Lower After A Brief Respite: &#39;Add Exposure To Equities&#39; Amid Pullback, Says Expert

Stock Movers

Movers

ANAB

ANNA

AREB

ASBP

CDLX

ELME

FAMI

HEPA

NOVA

SGBX

SNES

STGW

YOSH

Why Intel Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket

Anika Therapeutics Inc

Press Releases

Anika To Participate in 43rd Annual J.P. Morgan Healthcare Conference

Anika To Present at the Canaccord Genuity 2025 Musculoskeletal Conference

Anika to Issue Fourth Quarter and Year-End 2024 Financial Results on Wednesday, March 12, 2025

Contracts

Anika Completes Divestiture of Parcus Medical

Anika Reports Fourth Quarter and Full Year 2024 Financial Results

Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Anika to Issue First Quarter 2025 Financial Results on Friday, May 9, 2025

Anika to Participate in the Sidoti Virtual Investor Conference

Anika Reports First Quarter 2025 Financial Results

Actuate Therapeutics, Inc. - Common stock

Actuate Therapeutics

Alector

Editas Medicine

Eledon Pharmaceuticals, Inc. - Common Stock

Eledon Pharmaceuticals

Enanta Pharmaceuticals, Inc. - Common Stock

Enanta Pharma

Fate Therapeutics

4D Molecular Therapeutics, Inc. - Common Stock

4D Molecular Therapeutics

Inhibikase Therapeutics, Inc. - Common Stock

Inhibikase Therapeutics

I-MAB

Inhibrx Biosciences

INmune Bio

Innate Pharma S.A. - American Depositary Shares

Innate Pharma

Lineage Cell Therapeutics, Inc. Common Stock

Lineage Cell Therapeutics

Larimar Therapeutics, Inc. - Common Stock

Larimar Therapeutics

Monopar Therapeutics

Nanobiotix

Nuvectis Pharma

Puma Biotechnology

Prime Medicine

AVITA Medical

SELLAS Life Sciences Group, Inc. - Common Stock

SELLAS Life Sciences Gr

Instil Bio

Tiziana Life Sciences Ltd - Common Shares

Tiziana Life Sciences

Voyager Therapeutics, Inc. - Common Stock

Voyager Therapeutics

Exagen

Barrington Research

Stephens & Co.

Comments

Anika Therapeutics

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell